Deal & Cases
01. June 2021
The French fund is aimed at supporting the clinical development and the market access of breakthrough drugs.
The team included Philippe Jacquemoud and Aurélie Guex-Croisier
The team included Philippe Jacquemoud and Aurélie Guex-Croisier